Russell Investments Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$308K Buy
16,457
+6,746
+69% +$126K ﹤0.01% 2512
2025
Q1
$175K Buy
9,711
+512
+6% +$9.21K ﹤0.01% 2629
2024
Q4
$155K Sell
9,199
-1,349
-13% -$22.7K ﹤0.01% 2597
2024
Q3
$171K Buy
10,548
+124
+1% +$2.01K ﹤0.01% 2549
2024
Q2
$85.7K Sell
10,424
-1,322
-11% -$10.9K ﹤0.01% 2662
2024
Q1
$174K Sell
11,746
-2,810
-19% -$41.6K ﹤0.01% 2476
2023
Q4
$211K Sell
14,556
-4,772
-25% -$69.2K ﹤0.01% 2422
2023
Q3
$209K Sell
19,328
-1,790
-8% -$19.3K ﹤0.01% 2479
2023
Q2
$272K Sell
21,118
-40
-0.2% -$516 ﹤0.01% 2407
2023
Q1
$279K Buy
21,158
+5,589
+36% +$73.8K ﹤0.01% 2410
2022
Q4
$234K Buy
15,569
+622
+4% +$9.33K ﹤0.01% 2532
2022
Q3
$175K Buy
14,947
+14,070
+1,604% +$165K ﹤0.01% 2574
2022
Q2
$9K Sell
877
-8,245
-90% -$84.6K ﹤0.01% 2848
2022
Q1
$272K Buy
9,122
+1,165
+15% +$34.7K ﹤0.01% 2394
2021
Q4
$210K Sell
7,957
-488
-6% -$12.9K ﹤0.01% 2706
2021
Q3
$305K Hold
8,445
﹤0.01% 2645
2021
Q2
$365K Sell
8,445
-17,305
-67% -$748K ﹤0.01% 2711
2021
Q1
$879K Sell
25,750
-34,245
-57% -$1.17M ﹤0.01% 2302
2020
Q4
$2.1M Sell
59,995
-33,060
-36% -$1.16M ﹤0.01% 1733
2020
Q3
$2.23M Buy
93,055
+30,200
+48% +$723K ﹤0.01% 1612
2020
Q2
$1.15M Buy
62,855
+16,579
+36% +$303K ﹤0.01% 1976
2020
Q1
$719K Buy
46,276
+42,536
+1,137% +$661K ﹤0.01% 2005
2019
Q4
$79K Sell
3,740
-6,290
-63% -$133K ﹤0.01% 2934
2019
Q3
$188K Sell
10,030
-3,746
-27% -$70.2K ﹤0.01% 2630
2019
Q2
$359K Buy
13,776
+10,686
+346% +$278K ﹤0.01% 2371
2019
Q1
$80K Buy
+3,090
New +$80K ﹤0.01% 2755
2017
Q1
Sell
-19,075
Closed -$459K 3058
2016
Q4
$459K Buy
+19,075
New +$459K ﹤0.01% 2496